Cannabics Pharmaceuticals Inc. announced development of Cannabics 5mg THC Capsule intended for naïve patient who have not tried cannabis in the past. The Cannabics 5mg THC capsule is currently being evaluated by the company in a clinical study as a palliative treatment, which is conducted by the oncology department at the prestigious Rambam Medical Center in northern Israel and under strict regulations of the Ministry of Health, by whom Cannabics Pharmaceuticals has been licensed since 2014.